(Q44642090)

4 December 2017

Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population (English)

1 reference

4 December 2017

0 references

0 references

0 references

7

1 reference

4 December 2017

Gazzerro P

1

1 reference

4 December 2017

Caruso MG

2

1 reference

4 December 2017

Notarnicola M

3

1 reference

4 December 2017

Misciagna G

4

1 reference

4 December 2017

Guerra V

5

1 reference

4 December 2017

Laezza C

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

12 December 2006

1 reference

International Journal of Obesity

4 December 2017

1 reference

4 December 2017

31

1 reference

4 December 2017

6

1 reference

4 December 2017

908-912

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803510

4 December 2017

0 references

cites work

What is the economic case for treating obesity?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

Cannabinoid receptors and their endogenous agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

Activation of the peripheral endocannabinoid system in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

inferred from DOI database lookup

7 January 2021

based on heuristic

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803510

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.IJO.0803510

1 reference

Dimensions Publication ID

4 December 2017

0 references

1 reference